Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd.SSE: 688505

Report for Q3 2024

Oct 26, 2024 · Issued by Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 26, 2024

On 6ix: 6ix.com/news/report-for-q3-2024-431

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. on 6ix

Earlier from Shanghai Fudan Zhangjiang Bio Pharmaceutical

Announcement on Convening Performance Briefing for Q3 2024Oct 19, 2024
Announcement on Voluntary Disclosure of the Completion of Enrollment of the First Subject in the Phase II Clinical Trial of Hemoporfin for Injection for the Treatment of Nevus Flammeus in the United StatesSep 24, 2024
Announcement on Participating in the 2024 Semi-annual Special Collective Performance Briefing for Pharmaceutical and Biological ProductsSep 6, 2024
Announcement on Voluntary Disclosure of the Completion of the First Subject Enrollment in Phase III Clinical Trial of FDA018 Antibody-drug Conjugate for the Treatment of Triple-negative Breast CancerAug 27, 2024
Announcement on the Implementation of Semi-annual Dividend Distribution in 2024Aug 22, 2024

Later from Shanghai Fudan Zhangjiang Bio Pharmaceutical

Announcement on Voluntary Disclosure of the Acceptance of Drug Marketing Application for Obeticholic Acid Tablets for the Treatment of Primary Biliary CholangitisNov 1, 2024
Announcement on Obtaining Government SubsidiesDec 31, 2024
Announcement on 2024 Annual Earnings PreannouncementJan 18, 2025
Preliminary Earnings Estimate for 2024Feb 28, 2025
Announcement on Expiration of Plan of Shareholding Reduction by Shareholders with Over 5% Shares and Results of Shareholding ReductionMar 7, 2025

All Shanghai Fudan Zhangjiang Bio Pharmaceutical news releases

Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical